Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

View all →   RSSRecent Releases
Feb 13, 2017 Celldex Therapeutics Announces Upcoming Investor Presentations and 2016 Year-End Call
Dec 14, 2016 Celldex Therapeutics Announces Appointment to Board of Directors
More →Upcoming Events
Mar 7, 2017
9:20 AM
Cowen and Company 37th Annual Health Care Conference
Mar 14, 2017
4:30 PM ET
Celldex Therapeutics Year End 2016 Conference Call
Featured Financial Reports
Filing Date Title Type Size
Nov 7, 2016 Form 10-Q View HTML View PDF 350.7 KB Add to Briefcase
Feb 25, 2016 Form 10-K/A View HTML View PDF 1.1 MB Add to Briefcase
Add to Briefcase = add file to Briefcase